ga naar hoofdinhoud
Vademecum Gynaecologische tumoren Cervixcarcinoom Literatuur en richtlijnen

Literatuur

  1. Morris M et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 1999 Apr 15; 340(15):1137-43
  2. Rose PG et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999 Apr 15; 340(15):1144-53. Erratum in: N Engl J Med 1999 Aug 26; 341(9):708
  3. Green JA et al. Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix (review). Cochrane Database Syst Rev 2005; 20(3):CD002225
  4. K. Katanyoo et al. Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients. Gynecologic Oncology 2011; 123:571–576
  5. P. Zusterzeel et al. Neoadjuvant chemotherapy followed by vaginal radical trachelectomy as fertility‐preserving treatment for patients with FIGO 2018 stage 1B2 cervical cancer. The Oncologist 2020; 25:1–9
  6. Peters WA et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early stage cancer of the cervix. J Clin Oncol 2000; 18:1606-1613
  7. Rosa DD et al. Adjuvant platinum-based chemotherapy for early stage cervical cancer. Cochrane Database of Syst Rev 2009; 3(3):CD005342
  8. Monk BJ et al. Rethinking the use of radiation and chemotherapy after radical hysterectomy: a clinical-pathologic analysis of a Gynaecologic Oncology Group / Southwest Oncology Group / Radiation Therapy Oncology Group Trial. Gynaecol Oncology 2005; 96:721-728
  9. Tewari KS et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med 2014; 370:734-743
  10. Colombo N et al. KEYNOTE826 investigators. Pembrolizumab for persistent, recurrent, or metastatic cervical cancer. N Engl J Med 2021; 385(20):185667
  11. Kitagawa R et al. Paclitaxel plus carboplatin versus paclitaxel plus cisplatin in metastatic or recurrent cervical cancer: the open-label randomized phase III trial JCOG0505. J Clin Oncol 2015; 33:2129-2135
  12. Long HJ et al. Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a gynecologic oncology group study. J Clin Oncol 2005 July 20 23(21):4626-4633
  13. Torfs S. et al. Evaluation of paclitaxel/carboplatin in a dose dense or weekly regimen in 66 patients with recurrent or primary metastatic cervical cancer. European Journal of Cancer 48; 2012
  14. Jaime Coronel et al. Weekly topotecan as second- or third-line treatment in patients with recurrent or metastatic cervical cancer. Medical Oncology 2009 vol 26, p210–214
  15. Salvo G et al. Updates and management algorithm for neuroendocrine tumors of the uterine cervix. Int J Gynecol Cancer 2019; 29:986–995

Commissie BOM adviezen

Ga naar de commissie BOM adviezen over cervixcarcinoom.

Richtlijnen

Ga naar de richtlijn Cervixcarcinoom in de FMS richtlijnen­database.